Alkermes
safety profile of subcutaneous consistent with mechanism of action and | Alkermes
Company
Deck Type
Sector
Industry
Deck date
June 2021
Slide
24 of 31
Similar slides by Alkermes
See diffirences between slides (animation)
Investor Day
March 2021
safety profile of consistent with mechanism of action and artistry safety regimens selected declared as based on totality of data dose may offer additional flexibility in treating certain tumor types and or in combination settings in the future maximum tolerated doses for were determined to be and no additional toxicities were reported in combination with most commonly reported at chills pyrexia fatigue nausea lymphopenia injection site reactions ast alt increase are most frequently reported treatment related adverse events aes majority anticipated effects of administration transient majority grade in severity most frequent grade was no treatment related discontinuations or deaths safety profile was consistent with most frequent grade was ast alt increase patient no treatment related discontinuations or deaths at three reported at of and were manageable with either dose interruption discontinuation and or standard of care treatment atypical capillary leak syndrome without hypotension grade injection site reaction grade transient fatigue nausea vomiting grade treatment related adverse events dose limiting toxicities maximum tolerated dose recommended phase dose serious adverse event subcutaneous intravenous data as of mar alkermes | Alkermes
Related slides by other companies
Immatics
Investor Presentation
November 2023
gen in cohort a most frequent adverse events | Immatics
Immatics
Investor Presentation
November 2023
gen in all melanoma patients at most frequent adverse events so | Immatics
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights